awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36852277-760C981A-1BEF-46D3-BDE5-AEB7D0091BCC
Q36852277-760C981A-1BEF-46D3-BDE5-AEB7D0091BCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852277-760C981A-1BEF-46D3-BDE5-AEB7D0091BCC
From bortezomib to other inhibitors of the proteasome and beyond.
P2860
Q36852277-760C981A-1BEF-46D3-BDE5-AEB7D0091BCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36852277-760C981A-1BEF-46D3-BDE5-AEB7D0091BCC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
565a9bd90b42e9e43f479f4a838095bf3005787e
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).